This cluster of papers focuses on the Fibroblast Growth Factor (FGF) signaling pathway, covering its role in development, metabolism, cancer, and therapy. It explores the involvement of FGF21, FGF receptors, and PPARa in various physiological processes such as hepatic lipid metabolism, insulin sensitivity, and bone development. Additionally, it discusses the potential therapeutic implications of targeting FGF signaling in conditions like obesity and cancer.